Publication Cover
Stress
The International Journal on the Biology of Stress
Volume 15, 2012 - Issue 4
212
Views
10
CrossRef citations to date
0
Altmetric
Original Research Reports

Induction of arginine vasopressin-enhanced green fluorescent protein expression in the locus coeruleus following kainic acid-induced seizures in rats

, , , , , , , , & show all
Pages 435-442 | Received 11 May 2011, Accepted 22 Sep 2011, Published online: 05 Dec 2011

References

  • Aguilera G, Rabadan-Diehl C. 2000. Vasopressinergic regulation of the hypothalamic–pituitary–adrenal axis: Implications for stress adaptation. Regul Pept. 96:23–29.
  • Ahmed MM, Yamamoto M, Chikuma T, Rahman MM, Kato T. 2003. Dose-dependent effect of MK-801 on the level of neuropeptides processing enzymes in rat brain regions. Neurosci Res. 47:177–189.
  • Ben-Ari Y. 1985. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:375–403.
  • Ben-Ari Y, Tremblay D, Riche D, Ghilini G, Naquet R. 1982. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: Metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience. 6:1361–1391.
  • Bengzon J, Hansson SR, Hoffman BJ, Lndvall O. 1999. Regulation of norepinephrine transporter and tyrosine hydroxylase mRNAs after kainic acid-induced seizures. Brain Res. 842:239–242.
  • Berod A, Chat M, Paut L, Tappaz M. 1984. Catecholaminergic and GABAergic anatomical relationship in the rat substantia nigra, locus coeruleus, and hypothalamic median eminence. J Histochem Cytochem. 32:1331–1338.
  • Caffe AR, van Leeuwen FW, Buijs RM, de Vries GJ, Geffard M. 1985. Coexistence of vasopressin, neurophysin and noradrenaline immunoreactivity in medium-sized cells of the locus coeruleus and subcoeruleus in the rat. Brain Res. 338:160–164.
  • Caldwell HK, Lee H-J, Macbeth AH, Young WSIII. 2008. Vasopressin: Behavioral Roles of an “Original” Neuropeptide. Prog Neurobiol. 84 1: 1–24.
  • Chen Y, Bender RA, Frotscher M, Baram TZ. 2001. Novel and transient populations of corticotrophin-releasing hormone-expressing neurons in developing hippocampus suggest unique functional roles: Quantitative spatiotemporal analysis. J Neurosci. 21:7171–7181.
  • Collins RC, McLean M, Olney JW. 1980. Cerebral metabolic response to systemic kainic acid: 14-C-deoxyglucose studies. Life Sci. 27:855–862.
  • Gallagher BB, Murvin A, Flanigin HF, King DW, Luney D. 1984. Pituitary and adrenal function in epileptic patients. Epilepsia. 25:683–689.
  • Guoying B, Belinda W, Pearlie H, Lei J, Zhehui F, Wanqin Z, Renjie B, Jau-Shyong H. 1997. A single dose of kainic acid elevates the levels of enkephalins and activator protein-1 transcription factors in the hippocampus for up to 1 year. Neurobiology. 94 17: 9422–9427.
  • Kalia M, Fuxe K, Goldstein M. 1985. Rat medulla oblongata. II. Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers, and presumptive terminal process. J Comp Neurol. 233:308–332.
  • Kim HC, Jhoo WK, Kim WK, Suh JH, Shin EJ, Kato K, Ko KH. 2000. An Immunocyto-chemical study of mitochondrial manganese-superoxide in the rat hippocampus after kainite administration. Neurosci Lett. 281:65–68.
  • Koob GF. 2008. A role for brain stress systems in addiction. Neuron. 59:11–34.
  • Landgraf R, Neumann ID. 2004. Vasopressin and oxytocin release within the brain: A dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol. 25:150–176.
  • Nomura M, Ueta Y, Hannibal J, Serino R, Yamamoto Y, Shibuya I, Matsumoto T, Yamashita H. 2000. Induction of pituitary adenylate cyclase-activating polypeptide mRNA in the medial parvocellular part of the paraventricular nucleus of rats following kainic-acid-induced seizure. Neuroendocrinology. 71:318–326.
  • Piekut D, Phipps B. 1998. Increased corticotropin-releasing factor immunoreactivity in selected brain sites following kainic elicited seizures. Brain Res. 781:100–113.
  • Piekut D, Phipps B, Pretel S, Applegate C. 1996. Increased corticotropin-releasing factor neuronal systems. Brain Res. 743:63–69.
  • Racine RJ. 1972. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroenceph clin Neurophysiol. 32:281–294.
  • Sakamoto K, Saito T, Orman R, Koizumi K, Lazar J, Salciccioli L, Stewart M. 2008. Autonomic consequences of kainic acid-induced limbic cortical seizures in rats: Peripheral autonomic nerve activity, acute cardiovascular changes, and death. Epilepsia. 49:982–996.
  • Samuels ER, Szabadi E. Functional Neuroanatomy of the noradrenergic locus coeruleus: Its roles in the regulation of arousal and autonomic function part I: Principles of functional organisation. Curr Neuropharmacol. 2008a; 6 3: 235–253.
  • Samuels ER, Szabadi E. Functional Neuroanatomy of the noradrenergic locus coeruleus: Its roles in the regulation of arousal and autonomic function part II: Physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Curr Neuropharmacol. 2008b; 6 3: 254–285.
  • Schauwecker PE, Steward O. 1997. Genetic determinants of susceptibility to excitotoxic cell death: Imprications for gene targeting approaches. Proc Natl Acad Sci USA. 94:4103–4108.
  • Shouse MN, Staba RJ, Ko PY, Saquib SF, Farber PR. 2001. Monoamines and seizures: Microdialysis findings in locus coeruleus and amygdale before and during amygdale kindling. Brain Res. 892:176–192.
  • Silveira DC, Liu Z, Holmes GL, Schomer DL, Schchter SC. Seizures in rats treated with kainic acid induce Fos-like immunoreactivity in locus coeruleus. Neuroreport. 1998a; 9:1353–1357.
  • Silveira DC, Liu Z, LaCalle S, Lu J, Klein P, Holmes GL, Herzog AG. Activation of the locus coeruleus after amygdaloid kindling. Epilepsia. 1998b; 39:1261–1264.
  • Sun Q, Pretel S, Applegate CD, Piekut DT. 1996. Oxytocin and vasopressin mRNA expression in rat hypothalamus following kainic acid-induced seizures. Neuroscience. 71:543–554.
  • Swanson LW, Sawchenko PE, Rivier J, Vale WW. 1983. Organization of ovine corticotrophin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology. 36:165–186.
  • Todoroki M, Ueta Y, Fujihara H, Otsubo H, Shibata M, Hashimoto H, Kobayashi M, Sakamoto H, Kawata M, Dayanithi G, Murphy D, Hiro H, Takahashi K, Nagata S. 2010. Induction of the arginine vasopressin-enhanced green fluorescent protein fusion transgene in the rat locus coeruleus. Stress. 13 4: 281–292.
  • Tobin VA, Hashimoto H, Wacker DW, Takayanagi Y, Langnaese CC, Noack J, Landgraf R, Onaka T, Leng G, Meddle SL, Engelmann M, Ludwig M. 2010. An intrinsic vasopressin system in the olfactory bulb is involved in social recognition. Nature. 464 7287: 413–417.
  • Ueta Y, Fujihara H, Serino R, Dayanithi G, Ozawa H, Matsuda K, Kawata M, Yamada J, Ueno S, Fukuda A, Murphy D. 2005. Transgenic expression of enhanced green fluorescent protein enables direct visualization for physiological studies of vasopressin neurons and isolated nerve terminals of the rat. Endocrinology. 146:406–413.
  • Valentino RJ, Van Bockstaele E. 2008. Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol. 583:215–225.
  • Virgili M, Migani P, Contestabile A, Barnabei O. 1992. Protection from kainic acid neuropathological syndrome by NMDA receptor antagonists: Effect of MK-801 and CG 39551 on neurotransmitter and glial markers. Neuropharmacology. 31:469–474.
  • Westfall TC, Westfall DP. 2006. Neurotransmission: The automatic and somatic motor nervous systems. In: Brunton LL, Laoz JS, Parker DP. editors. Goodman & Gilman's the pharmacological basis of therapeutics. New York, NY: McGraw-Hill137–182.
  • Wilkinson MF, Pittman QJ. 1994. Alteration of the physiological responses to indomethacin by endotoxin tolerance in the rat: A possible role for central vasopressin. J Physiol. 479.3:441–449.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.